(Q51534265)
Statements
Reslizumab for Inadequately Controlled Asthma With Elevated Blood Eosinophil Levels: A Randomized Phase 3 Study. (English)
1 reference
Leif Bjermer
1 reference
Catherine Lemiere
1 reference
Jorge Maspero
1 reference
Sivan Weiss
1 reference
James Zangrilli
1 reference
Matthew Germinaro
1 reference
4 April 2016
1 reference
1 reference
150
1 reference
4
1 reference
789-798
1 reference